More about

Houston Methodist

News
November 09, 2024
1 min read
Save

Manipulation under anesthesia, lysis of adhesion after TKA may improve knee flexion

DALLAS —Successful manipulation under anesthesia with or without lysis of adhesion after total knee arthroplasty may provide a gain of 30° of knee flexion, according to data presented here.

News
May 09, 2024
4 min read
Save

AI, new technology major focus at 2024 AACE annual meeting

Looking to the future will be a key theme at the American Association of Clinical Endocrinology 2024 annual meeting with a keynote lecture focused on AI and sessions examining guidance updates and new technology.

News
February 28, 2024
3 min read
Save

New data ‘challenge’ understanding of simple vs. radical hysterectomy for cervical cancer

Simple hysterectomy is not inferior to radical hysterectomy in terms of 3-year incidence of pelvic disease recurrence among women with low-risk cervical cancer, according to study data published in The New England Journal of Medicine.

News
August 01, 2023
2 min read
Save

Mayo Clinic repeats as top US hospital for diabetes, endocrinology

The Mayo Clinic in Rochester, Minnesota, is the No. 1 hospital in the U.S. for diabetes and endocrinology, according to the 2023-2024 Best Hospitals rankings released by U.S. News & World Report.

News
April 12, 2023
2 min read
Save

Rates of radiographic knee osteoarthritis similar between runners, non-runners

Moderate-distance runners and non-runners alike demonstrate similar rates of radiographic knee osteoarthritis, according to systematic review data published in the Orthopaedic Journal of Sports Medicine.

News
March 03, 2023
2 min read
Save

No serious paravalvular leak at 30 days in study of next-generation TAVR system

In the PORTICO NG study of a next-generation transcatheter aortic valve replacement system, there were no cases of moderate or greater paravalvular leak at 30 days, researchers reported at Cardiovascular Research Technologies.

News
February 18, 2023
4 min read
Save

Niraparib regimen improves outcomes for men with prostate cancer, HRR gene alterations

SAN FRANCISCO — The addition of niraparib to abiraterone acetate and prednisone improved multiple outcomes for certain men with metastatic castration-resistant prostate cancer, according to randomized phase 3 study results.

News
February 08, 2023
2 min read
Save

Data show aspirin has limited role in patients without CAD

Among adults without CAD, the absolute risk for major bleeding with aspirin as primary prevention therapy exceeds the any absolute MI benefits for every level of atherosclerotic CVD risk, data from a meta-analysis show.

News
November 14, 2022
3 min read
Save

Clinical models with CAC score improve CAD risk stratification

In suspected obstructive CAD, clinical models with risk factors and a coronary artery calcium score identified up to 3.5 times more patients who may not benefit from further diagnostic testing vs. a basic pretest probability model.

News
October 17, 2022
7 min read
Save

Cell therapy pioneer: Modality could be solution to ‘pretty large cadre’ of diseases

The basic science discoveries to which Helen E. Heslop, MD, DSc (Hon), has contributed place her firmly on the Mount Rushmore of pioneers in the field of gene and cell therapy.

View more